158 related articles for article (PubMed ID: 20670949)
1. Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.
Fu M; Maresh EL; Soslow RA; Alavi M; Mah V; Zhou Q; Iasonos A; Goodglick L; Gordon LK; Braun J; Wadehra M
Clin Cancer Res; 2010 Aug; 16(15):3954-63. PubMed ID: 20670949
[TBL] [Abstract][Full Text] [Related]
2. Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines.
Shimazaki K; Lepin EJ; Wei B; Nagy AK; Coulam CP; Mareninov S; Fu M; Wu AM; Marks JD; Braun J; Gordon LK; Wadehra M
Clin Cancer Res; 2008 Nov; 14(22):7367-77. PubMed ID: 19010852
[TBL] [Abstract][Full Text] [Related]
3. Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.
Fu M; Maresh EL; Helguera GF; Kiyohara M; Qin Y; Ashki N; Daniels-Wells TR; Aziz N; Gordon LK; Braun J; Elshimali Y; Soslow RA; Penichet ML; Goodglick L; Wadehra M
Mol Cancer Ther; 2014 Apr; 13(4):902-15. PubMed ID: 24448822
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.
Fu M; Brewer S; Olafsen T; Wu AM; Gordon LK; Said J; Braun J; Wadehra M
Mol Imaging Biol; 2013 Feb; 15(1):68-78. PubMed ID: 22585360
[TBL] [Abstract][Full Text] [Related]
5. EMP2 is a novel therapeutic target for endometrial cancer stem cells.
Kiyohara MH; Dillard C; Tsui J; Kim SR; Lu J; Sachdev D; Goodglick L; Tong M; Torous VF; Aryasomayajula C; Wang W; Najafzadeh P; Gordon LK; Braun J; McDermott S; Wicha MS; Wadehra M
Oncogene; 2017 Oct; 36(42):5793-5807. PubMed ID: 28604744
[TBL] [Abstract][Full Text] [Related]
6. Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome.
Wadehra M; Natarajan S; Seligson DB; Williams CJ; Hummer AJ; Hedvat C; Braun J; Soslow RA
Cancer; 2006 Jul; 107(1):90-8. PubMed ID: 16736513
[TBL] [Abstract][Full Text] [Related]
7. Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells.
Morales SA; Telander DG; Mareninov S; Nagy A; Wadehra M; Braun J; Gordon LK
Exp Eye Res; 2012 Sep; 102():10-6. PubMed ID: 22728127
[TBL] [Abstract][Full Text] [Related]
8. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
Qin Y; Takahashi M; Sheets K; Soto H; Tsui J; Pelargos P; Antonios JP; Kasahara N; Yang I; Prins RM; Braun J; Gordon LK; Wadehra M
J Neurooncol; 2017 Aug; 134(1):29-40. PubMed ID: 28597184
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies.
Faratian D; Zweemer AJ; Nagumo Y; Sims AH; Muir M; Dodds M; Mullen P; Um I; Kay C; Hasmann M; Harrison DJ; Langdon SP
Clin Cancer Res; 2011 Jul; 17(13):4451-61. PubMed ID: 21571868
[TBL] [Abstract][Full Text] [Related]
10. Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.
Habeeb O; Goodglick L; Soslow RA; Rao RG; Gordon LK; Schirripa O; Horvath S; Braun J; Seligson DB; Wadehra M
Cancer; 2010 Oct; 116(20):4718-26. PubMed ID: 20578181
[TBL] [Abstract][Full Text] [Related]
11. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas.
Chung LK; Pelargos PE; Chan AM; Demos JV; Lagman C; Sheppard JP; Nguyen T; Chang YL; Hojat SA; Prins RM; Liau LM; Nghiemphu L; Lai A; Cloughesy TF; Yong WH; Gordon LK; Wadehra M; Yang I
Brain Tumor Pathol; 2018 Jan; 35(1):1-9. PubMed ID: 28887715
[TBL] [Abstract][Full Text] [Related]
12. EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF.
Gordon LK; Kiyohara M; Fu M; Braun J; Dhawan P; Chan A; Goodglick L; Wadehra M
Oncogene; 2013 Nov; 32(46):5369-76. PubMed ID: 23334331
[TBL] [Abstract][Full Text] [Related]
13. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.
Qin Y; Fu M; Takahashi M; Iwanami A; Kuga D; Rao RG; Sudhakar D; Huang T; Kiyohara M; Torres K; Dillard C; Inagaki A; Kasahara N; Goodglick L; Braun J; Mischel PS; Gordon LK; Wadehra M
J Biol Chem; 2014 May; 289(20):13974-85. PubMed ID: 24644285
[TBL] [Abstract][Full Text] [Related]
14. Steroid hormone regulation of EMP2 expression and localization in the endometrium.
Wadehra M; Mainigi M; Morales SA; Rao RG; Gordon LK; Williams CJ; Braun J
Reprod Biol Endocrinol; 2008 Apr; 6():15. PubMed ID: 18400107
[TBL] [Abstract][Full Text] [Related]
15. hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.
Wittinger M; Vanhara P; El-Gazzar A; Savarese-Brenner B; Pils D; Anees M; Grunt TW; Sibilia M; Holcmann M; Horvat R; Schemper M; Zeillinger R; Schöfer C; Dolznig H; Horak P; Krainer M
Clin Cancer Res; 2011 Dec; 17(24):7816-27. PubMed ID: 22016507
[TBL] [Abstract][Full Text] [Related]
16. The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.
Li CF; Wu WJ; Wu WR; Liao YJ; Chen LR; Huang CN; Li CC; Li WM; Huang HY; Chen YL; Liang SS; Chow NH; Shiue YL
Oncotarget; 2015 Apr; 6(11):9220-39. PubMed ID: 25940704
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer.
Papadia A; Schally AV; Halmos G; Varga JL; Seitz S; Buchholz S; Rick F; Zarandi M; Bellyei S; Treszl A; Szalontay L; Lucci JA
Horm Metab Res; 2011 Oct; 43(11):816-20. PubMed ID: 22009378
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.
Moran-Jones K; Gloss BS; Murali R; Chang DK; Colvin EK; Jones MD; Yuen S; Howell VM; Brown LM; Wong CW; Spong SM; Scarlett CJ; Hacker NF; Ghosh S; Mok SC; Birrer MJ; Samimi G
Oncotarget; 2015 Dec; 6(42):44551-62. PubMed ID: 26575166
[TBL] [Abstract][Full Text] [Related]
19. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
Nielsen UB; Adams GP; Weiner LM; Marks JD
Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
